Tuesday’s Midday Movers: Organovo Holdings (ONVO), Fuelcell Energy (FCEL), Clovis Oncology (CLVS), Bluebird Bio (BLUE), Plug Power (PLUG)

By Carrie Williams

So far Tuesday, February 16, NASDAQ is down -4.38% and the S&P is down -1.44%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Organovo Holdings (ONVOResearch Report), Fuelcell Energy (FCELResearch Report), Clovis Oncology (CLVSResearch Report), Bluebird Bio (BLUEResearch Report) and Plug Power (PLUGResearch Report).

Organovo Holdings is down -9.97% in midday trading to $18.34. Shares opened today at $20.37. The company has a 52-week low of $3.87 and a 52-week high of $23.92.

Fuelcell Energy is down -9.83% in midday trading to $23.84. Shares opened today at $26.44. The company has a 52-week low of $1.00 and a 52-week high of $29.44. On the Street’s front, the average 12-month analyst price target for the stock is $10.25, marking a -61.23% potential downside from current levels. In a report issued on January 21, Canaccord Genuity analyst Jonathan Dorsheimer maintained a Hold rating on FCEL, with a price target of $15.00, which implies a downside of 43% from current levels. Separately, on January 14, J.P. Morgan’s Paul Coster downgraded the stock to Sell and has a price target of $10.00. In the last 30 days, insiders purchased $8,467 worth of FCEL shares.

Clovis Oncology is down -9.75% in midday trading to $7.22. Shares opened today at $8.00. The company has a 52-week low of $3.62 and a 52-week high of $11.63. On the Street’s front, the average 12-month analyst price target for the stock is $10.00, marking a 25.00% potential upside from current levels. In a report issued on February 11, H.C. Wainwright analyst Edward White maintained a Buy rating on CLVS, with a price target of $15.00, which implies an upside of 88% from current levels. Separately, on January 12, J.P. Morgan’s Cory Kasimov assigned a Hold rating to the stock . In the last 30 days, insiders purchased $412.8K worth of CLVS shares.

See today’s analyst top recommended stocks >>

Bluebird Bio is down -9.55% in midday trading to $30.30. Shares opened today at $33.50. The company has a 52-week low of $38.95 and a 52-week high of $92.00. On the Street’s front, the average 12-month analyst price target for the stock is $73.17, marking a 118.42% potential upside from current levels. In a report released today, Mizuho analyst Difei Yang downgraded BLUE to Hold, with a price target of $34.00, which represents a slight upside potential from current levels. Separately, on January 12, Canaccord Genuity’s John Newman maintained a Buy rating on the stock and has a price target of $86.00. In the last 30 days, insiders have sold $33.29K worth of BLUE shares. Over the last 3 months, the insider sentiment on Bluebird Bio has been negative based on 85 corporate insider transactions. This sentiment is lower than the average sector sentiment of insiders.

Plug Power is down -9.52% in midday trading to $58.82. Shares opened today at $65.01. The company has a 52-week low of $2.53 and a 52-week high of $75.49. On the Street’s front, the average 12-month analyst price target for the stock is $69.82, marking a 7.40% potential upside from current levels. In a report issued on February 3, Bernstein Research analyst Neil Beveridge initiated coverage with a Buy rating on PLUG and a price target of $75.00, which implies an upside of 15% from current levels. Separately, on January 27, Piper Sandler’s Pearce Hammond initiated coverage with a Hold rating on the stock and has a price target of $66.00. Over the last 3 months, the insider sentiment on Plug Power has been negative based on 121 corporate insider transactions. This sentiment is lower than the average sector sentiment of insiders.

See today’s analyst top recommended stocks >>

Trending Stocks Based on Insider Activity >>